Flomoxef

Drug Profile

Flomoxef

Alternative Names: 6315 S; Efmox; Flumarin; FMOX; S 6315

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shionogi
  • Developer ISF; Shionogi
  • Class Antibacterials; Cephalosporins; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Bacterial infections

Most Recent Events

  • 26 Jun 2000 Launched for Bacterial infections in Japan (IV)
  • 30 Jun 1998 Launched for Bacterial infections in China (IV)
  • 16 Feb 1995 Registered for Bacterial infections in Italy (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top